Oligomerix, Inc.
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Holding
- Established
- 2006-01-01
- Employees
- 1
- Market Cap
- -
- Website
- http://www.oligomerix.com
Phase 1 Study of OLX-07010 in Healthy Adult and Elderly Participants
Phase 1
- Conditions
- Alzheimer Disease
- Interventions
- Drug: OLX-07010 ActiveDrug: OLX-07010 Placebo
- First Posted Date
- 2023-01-25
- Last Posted Date
- 2025-05-18
- Lead Sponsor
- Oligomerix, Inc
- Target Recruit Count
- 88
- Registration Number
- NCT05696483
- Locations
- 🇺🇸
California Clinical Trials Medical Group, Inc, Glendale, California, United States